home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The RNAi Revolution Marches On

  March, 29 2006 9:23
your information resource in human molecular genetics
Scientists have taken an important step towards a new class of drug treatment that harnesses the RNA interference pathway. Reported online by Nature, a new study shows for the first time that systemic administration of small interfering RNA (siRNA) can be used in non-human primates to silence a disease-causing gene that is otherwise inaccessible to targeting with conventional therapies.

Tracy Zimmermann and colleagues exploit a normal cellular process, RNA interference (RNAi), to suppress the expression of a gene associated with heart disease. The authors have previously used a mouse model system, but here they study the effects of RNAi therapy in cynomolgus monkeys (Macaca fascicularis). They gave the monkeys a single injection of siRNA targeted against the gene for apolipoprotein B (ApoB), a protein involved in the secretion and assembly of low-density lipoprotein (LDL), the 'bad' cholesterol. Within 48 hours, the level of gene silencing exceeded 90%, leading to significant reductions in ApoB protein, serum cholesterol and LDL levels. The effect was also persistent, with ApoB gene expression being substantially reduced for at least 11 days.

This research has implications for diseases associated with high cholesterol levels, such as coronary heart disease, and continues to highlight RNAi as a promising therapeutic approach.

Author contact:

Tracy Zimmermann (Alnylam Pharmaceuticals, Cambridge, MA, USA)
E-mail: tzimmermann@alnylam.com

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.